A novel mitotic kinesin Eg5 inhibitor exerts the growth-inhibitory effect in cancer cells in a manner independent of induction of monoastral formation but dependent of KRAS mutation status

被引：0
|
作者：
Tanaka, Toshimitsu
机构：
来源：
MOLECULAR CANCER THERAPEUTICS | 2009年 / 8卷 / 12期
关键词：
D O I：
10.1158/1535-7163.TARG-09-C108
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
C108
引用
收藏
页数：3
相关论文
共 2 条
  • [1] A novel mitotic kinesin Eg5 inhibitor exerts the growth inhibitory effect on cancer cells in a manner independent of neither Eg5 expression level nor induction of monoastral formation
    Lee, H.
    Ogo, N.
    Asai, A.
    Boku, N.
    Koh, Y.
    EJC SUPPLEMENTS, 2009, 7 (02): : 124 - 124
  • [2] K858, a Novel Inhibitor of Mitotic Kinesin Eg5 and Antitumor Agent, Induces Cell Death in Cancer Cells
    Nakai, Ryuichiro
    Iida, Shin-ichi
    Takahashi, Takeshi
    Tsujita, Tetsuya
    Okamoto, Seiho
    Takada, Chie
    Akasaka, Kazuhito
    Ichikawa, Shunji
    Ishida, Hiroyuki
    Kusaka, Hideaki
    Akinaga, Shiro
    Murakata, Chikara
    Honda, Shinobu
    Nitta, Masayuki
    Saya, Hideyuki
    Yamashita, Yoshinori
    CANCER RESEARCH, 2009, 69 (09) : 3901 - 3909
1